-
Arch Biopartners Inc. (ARCH $1.69)
- $1.69 Cap: $114M
- View ARCH Profile
- View Questions on ARCH
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Arch Biopartners Inc. (ARCH $1.69)
- $1.69 Cap: $114M
- View ARCH Profile
- View Questions on ARCH
Q: Good day gurus,
I took the plunge on Arch a couple of months ago.
So far so good.
What do you think about its prospects/future trend?
Regards,
Dave
I took the plunge on Arch a couple of months ago.
So far so good.
What do you think about its prospects/future trend?
Regards,
Dave
-
Profound Medical Corp. (PRN $8.10)
- $8.10 Cap: $239M
- View PRN Profile
- View Questions on PRN
-
Arch Biopartners Inc. (ARCH $1.69)
- $1.69 Cap: $114M
- View ARCH Profile
- View Questions on ARCH
-
Medicenna Therapeutics Corp. (MDNA $0.84)
- $0.84 Cap: $70M
- View MDNA Profile
- View Questions on MDNA
Q: What are your top three picks in the Canadian Biotechnolgy sector, and what do you like about them.
Thanks!
Thanks!
-
Arch Biopartners Inc. (ARCH $1.69)
- $1.69 Cap: $114M
- View ARCH Profile
- View Questions on ARCH
Q: Could I get your opinion on Arch Biopartners and whether or not it would be a buy, hold or sell (for a 2-4year outlook). Symbol is ACH on the TSX Venture Exchange. Thank you.
Insiders
Share Information
News and Media